In the intricate world of chemical synthesis, specific intermediates act as foundational elements for a wide array of applications, particularly in the pharmaceutical sector. 5-Bromo-2-fluorobenzaldehyde (CAS: 93777-26-5) is one such critical compound, serving as a key building block for advanced therapeutic agents.

This organic molecule, with the chemical formula C7H4BrFO and a molecular weight of approximately 203.01 g/mol, is recognized for its utility as a pharmaceutical intermediate. Its primary significance lies in its role in the synthesis of Ipragliflozin, a drug belonging to the SGLT2 inhibitor class, used in the management of type 2 diabetes. The molecule's structure, featuring both bromine and fluorine atoms on a benzaldehyde ring, provides specific reactivity patterns essential for complex organic transformations.

As a manufacturer and supplier, NINGBO INNO PHARMCHEM CO.,LTD. offers 5-Bromo-2-fluorobenzaldehyde that meets high purity standards, typically ≥98.0%. This level of purity is vital for pharmaceutical applications, ensuring that the resulting APIs are safe and effective. The compound’s physical characteristics, often described as a light yellow liquid or crystal, necessitate proper storage in cool, ventilated conditions to maintain its quality over time.

For entities looking to buy 5-Bromo-2-fluorobenzaldehyde, understanding its price, packaging, and supplier reliability is key. Sourcing this fine chemical from reputable manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. guarantees access to materials that conform to industry specifications. This is particularly important for companies involved in the production of diabetes medications like Ipragliflozin, where consistent quality is non-negotiable.

The continued demand for advanced pharmaceuticals drives the need for high-quality intermediates. 5-Bromo-2-fluorobenzaldehyde exemplifies this requirement, serving as a cornerstone for innovative drug development. By providing this essential chemical, NINGBO INNO PHARMCHEM CO.,LTD. supports the pharmaceutical industry's efforts to bring new and improved treatments to patients worldwide, reinforcing its position as a crucial partner in chemical supply chains.